More cholesterol screening urged
This article was originally published in The Gray Sheet
Executive Summary
The U.S. health care system must do a better job of screening young adults for elevated low-density lipoprotein cholesterol - or bad cholesterol - according to a recent study by the Centers for Disease Control and Prevention. The study found that fewer than 50% of young adults are screened, regardless of risk factors, but about 55% of them have at least one risk factor. CDC reported elevated LDL cholesterol levels in 7% of young adults with no other risk factors for heart disease, in 12% of those with one other risk factor and in 26% of those with two or more. Elevated LDL cholesterol is a leading cause of heart disease. Other risk factors are hypertension, smoking, family history and obesity
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.